TSCAN THERAPEUTICS INC's ticker is and the CUSIP is 89854M101. A total of 33 filers reported holding TSCAN THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 1.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $664,184 | +144.9% | 259,447 | +139.2% | 0.00% | – |
Q2 2023 | $271,188 | -1.7% | 108,475 | -17.4% | 0.00% | – |
Q1 2023 | $275,770 | +321.9% | 131,319 | +211.4% | 0.00% | – |
Q4 2022 | $65,371 | -66.8% | 42,175 | -34.7% | 0.00% | – |
Q3 2022 | $197,000 | +9.4% | 64,570 | +13.1% | 0.00% | – |
Q2 2022 | $180,000 | +63.6% | 57,089 | +46.1% | 0.00% | – |
Q1 2022 | $110,000 | -10.6% | 39,076 | +42.6% | 0.00% | – |
Q4 2021 | $123,000 | -47.7% | 27,404 | -2.9% | 0.00% | – |
Q3 2021 | $235,000 | – | 28,236 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DC Funds, LP | 630,000 | $1,323,000 | 30.82% |
Deer Management Co. LLC | 1,245,505 | $2,615,561 | 0.24% |
Simplify Asset Management Inc. | 546,916 | $1,148,524 | 0.16% |
Alphabet Inc. | 1,077,080 | $2,261,868 | 0.12% |
Newtyn Management, LLC | 236,800 | $497,280 | 0.10% |
DC Investments Management, LLC | 35,563 | $74,682 | 0.09% |
Privium Fund Management (UK) Ltd | 15,825 | $40,987 | 0.03% |
Baker Brothers Advisors | 2,784,792 | $5,848,063 | 0.03% |
Tekla Capital Management LLC | 200,000 | $420,000 | 0.02% |
NewEdge Wealth, LLC | 91,463 | $192,072 | 0.01% |